NELLCOR PURITAN BENNETT BUY LIFTS MALLINCKRODT'S THIRD-QUARTER HEALTH CARE SALES; LASER INDUSTRIES' EPITOUCH HAIR REMOVAL SYSTEM REVENUE GROWTH TOPS 60%
This article was originally published in The Gray Sheet
Executive SummaryMallinckrodt's acquisition of respiratory products company Nellcor Puritan Bennett last August added one month of sales to the company's health care business in the first quarter, turning a potential revenue decline into a 14% increase. Health care sales for the three months ended Sept. 30 were $411.1 mil., up from $361.7 mil. a year ago, Mallinckrodt reported.
You may also be interested in...
Scrip’s on-the-ground team in Asia talks about how the regional and wider pharma industry and policymakers have responded so far to the spreading coronavirus outbreak, with a focus on the expedited development of potential drugs and vaccines.
Oncologic Drugs Advisory Committee votes 6-5 that ramucirumab’s benefit/risk profile is favorable in first-line lung cancer, but 13-2 that pivotal trial data do not support approval of Steba’s vascular-targeted, photodynamic therapy for low-risk prostate cancer.